DWD 81.06(3)(b)3.3. A health care provider documents in the medical record a plan to encourage the patient’s independence and decreased reliance on health care providers. DWD 81.06(3)(b)4.4. Management of the patient’s condition includes active treatment modalities during this period. DWD 81.06(3)(b)5.5. The additional 12 visits for passive treatment does not delay the required surgical or chronic pain evaluation required by this chapter. DWD 81.06(3)(b)6.6. Passive care is not necessary while the patient has chronic pain syndrome. DWD 81.06(3)(c)(c) Adjustment or manipulation of joints. For purposes of this paragraph, “adjustment or manipulation of joints” includes chiropractic and osteopathic adjustments or manipulations. All of the following guidelines apply to adjustment or manipulation of joints: DWD 81.06(3)(c)2.2. Maximum treatment frequency is up to 5 times per week for the first one to 2 weeks decreasing in frequency until the end of the maximum treatment duration period in subd. 3. DWD 81.06(3)(d)(d) Thermal treatment. For purposes of this paragraph, “thermal treatment” includes all superficial and deep heating and cooling modalities. Superficial thermal modalities include hot packs, hot soaks, hot water bottles, hydrocollators, heating pads, ice packs, cold soaks, infrared, whirlpool, and fluidotherapy. Deep thermal modalities include diathermy, ultrasound, and microwave. All of the following guidelines apply to thermal treatment: DWD 81.06(3)(d)1.b.b. Maximum treatment frequency is up to 5 times per week for the first one to 3 weeks decreasing in frequency until the end of the maximum treatment duration period in subd. 1. c. DWD 81.06(3)(d)1.c.c. Maximum treatment duration is 12 weeks in a clinical setting but only if given in conjunction with other therapies. DWD 81.06(3)(d)2.2. Home use of thermal modalities may be prescribed at any time during the course of treatment. Home use may only involve hot packs, hot soaks, hot water bottles, hydrocollators, heating pads, ice packs, and cold soaks that can be applied by the patient without health care provider assistance. Home use of thermal modalities does not require any special training or monitoring, other than that usually provided by the health care provider during an office visit. DWD 81.06(3)(e)(e) Electrical muscle stimulation. For purposes of this paragraph, “electrical muscle stimulation” includes galvanic stimulation, transcutaneous electrical nerve stimulation, interferential, and microcurrent techniques. All of the following guidelines apply to electrical muscle stimulation: DWD 81.06(3)(e)1.b.b. Maximum treatment frequency is up to 5 times per week for the first one to 3 weeks decreasing in frequency until the end of the maximum treatment duration period in subd. 1. c. DWD 81.06(3)(e)1.c.c. Maximum treatment duration is 12 weeks of treatment in a clinical setting but only if given in conjunction with other therapies. DWD 81.06(3)(e)2.2. Home use of an electrical stimulation device may be prescribed at any time during a course of treatment. Initial use of an electrical stimulation device shall be in a supervised setting in order to ensure proper electrode placement and patient education. All of the following guidelines apply to home use of an electrical muscle stimulation device: DWD 81.06(3)(e)2.b.b. Patient may use the electrical stimulation device for one month, at which time effectiveness of the treatment shall be reevaluated by a health care provider before continuing home use of the device. DWD 81.06(3)(f)(f) Mechanical traction. All of the following guidelines apply to mechanical traction: DWD 81.06(3)(f)1.b.b. Maximum treatment frequency is up to 3 times per week for the first one to 3 weeks decreasing in frequency until the end of the maximum treatment duration period in subd. 1. c. DWD 81.06(3)(f)1.c.c. Maximum treatment duration is 12 weeks in a clinical setting but only if used in conjunction with other therapies. DWD 81.06(3)(f)2.2. Home use of a mechanical traction device may be prescribed as follow-up to use of traction in a clinical setting if it has proven to be effective treatment and is expected to continue to be effective treatment. Initial use of a mechanical traction device shall be in a supervised setting in order to ensure proper patient education. All of the following guidelines apply to home use of a mechanical traction device: DWD 81.06(3)(f)2.b.b. Patient may use the mechanical traction device for one month, at which time effectiveness of the treatment shall be reevaluated by a health care provider before continuing home use of the device. DWD 81.06(3)(g)(g) Acupuncture treatments. For purposes of this paragraph, “acupuncture treatments” include endorphin-mediated analgesic therapy that includes classic acupuncture and acupressure. All of the following guidelines apply to acupuncture treatments: DWD 81.06(3)(g)2.2. Maximum treatment frequency is up to 3 times per week for one to 3 weeks decreasing in frequency until the end of the maximum treatment duration period in subd. 3. DWD 81.06(3)(h)(h) Manual therapy. For purposes of this paragraph, “manual therapy” includes soft tissue and joint mobilization, therapeutic massage, and manual traction. All of the following guidelines apply to manual therapy: DWD 81.06(3)(h)2.2. Maximum treatment frequency is up to 5 times per week for the first one to 2 weeks decreasing in frequency until the end of the maximum treatment duration period in subd. 3. DWD 81.06(3)(i)(i) Phoresis. For purposes of this paragraph, “phoresis” includes iontophoresis and phonophoresis. All of the following guidelines apply to phoresis: DWD 81.06(3)(i)2.2. Maximum treatment frequency is up to 3 times per week for the first one to 3 weeks decreasing in frequency until the end of the maximum treatment duration period in subd. 3. DWD 81.06(3)(i)3.3. Maximum treatment is 9 sessions of either iontophoresis or phonophoresis, or combination, to any one site, with a maximum duration of 12 weeks for all treatment. DWD 81.06(3)(j)(j) Bedrest. Prolonged restriction of activity and immobilization are detrimental to a patient’s recovery. Bedrest shall not be prescribed for more than 7 days. DWD 81.06(3)(k)(k) Spinal braces and other movement restricting appliances. All of the following guidelines apply to spinal braces and other movement-restricting appliances: DWD 81.06(3)(k)1.1. Bracing required for longer than 2 weeks shall be accompanied by active muscle strengthening exercise to avoid deconditioning and prolonged disability. DWD 81.06(3)(k)3.3. Treatment frequency is limited to intermittent use during times of increased physical stress or prophylactic use at work. DWD 81.06(3)(k)4.4. Maximum continuous duration is 3 weeks unless patient is status postfusion. DWD 81.06(4)(a)(a) Active treatment modalities shall be used as set forth in pars. (b) to (f). A health care provider’s use of active treatment modalities may extend past the 12-week limitation on passive treatment modalities so long as the maximum durations for the active treatment modalities are not exceeded. DWD 81.06(4)(b)(b) Education shall teach the patient about pertinent anatomy and physiology as it relates to spinal function for the purpose of injury prevention. Education includes training on posture, biomechanics, and relaxation. The maximum number of treatments is 3 visits, which include an initial education and training session and 2 follow-up visits. DWD 81.06(4)(c)(c) Posture and work method training shall instruct the patient in the proper performance of job activities. Topics include proper positioning of the trunk, neck and arms, use of optimum biomechanics in performing job tasks, and appropriate pacing of activities. Methods include didactic sessions, demonstrations, exercises, and simulated work tasks. The maximum number of treatments is 3 visits. DWD 81.06(4)(d)(d) Worksite analysis and modification shall examine the patient’s work station, tools, and job duties. A health care provider’s recommendations may be made for the alteration of the work station, selection of alternate tools, modification of job duties, and provision of adaptive equipment. The maximum number of treatments is 3 visits. DWD 81.06(4)(e)(e) Exercise, which is important to the success of an initial nonsurgical treatment program and a return to normal activity, shall include active patient participation in activities designed to increase flexibility, strength, endurance, or muscle relaxation. Exercise shall, at least in part, be specifically aimed at the musculature of the lumbosacral spine. Aerobic exercise and extremity strengthening may be performed as adjunctive treatment, but may not be the primary focus of the exercise program. DWD 81.06(4)(f)(f) Exercises shall be evaluated to determine if the desired goals are being attained. Strength, flexibility, and endurance shall be objectively measured. A health care provider may objectively measure the treatment response as often as necessary for optimal care after the initial evaluation. Subdivisions 1. and 2. govern supervised and unsupervised exercise, except for computerized exercise programs and health clubs, which are governed by s. DWD 81.13. DWD 81.06(4)(f)1.1. ‘Guidelines for supervised exercise.’ One goal of an exercise program shall be to teach the patient how to maintain and maximize any gains experienced from exercise. Self-management of the condition shall be promoted. All of the following guidelines apply to supervised exercise: DWD 81.06(4)(f)1.a.a. Maximum treatment frequency is 5 times for the first week decreasing to 3 times per week for the next 2 weeks and decreasing in frequency after the third week. DWD 81.06(4)(f)2.2. ‘Guidelines for unsupervised exercise.’ Unsupervised exercise shall be provided in the least intensive setting appropriate to the goals of the exercise program and may supplement or follow the period of supervised exercise. All of the following guidelines apply to unsupervised exercise: DWD 81.06(4)(f)2.a.a. Maximum treatment frequency is up to 3 visits for instruction and monitoring. DWD 81.06(5)(a)(a) Injection modalities are necessary as set forth in pars. (b) to (d). A health care provider’s use of injections may extend past the 12-week limit on passive treatment modalities so long as the maximum treatment for injections is not exceeded. DWD 81.06(5)(b)(b) For purposes of this subsection, “therapeutic injections” include injections of trigger points, facet joints, facet nerves, sacroiliac joints, sympathetic nerves, epidurals, nerve roots, and peripheral nerves. Therapeutic injections may only be given in conjunction with active treatment modalities directed to the same anatomical site. DWD 81.06(5)(b)1.1. All of the following guidelines apply to trigger point injections: DWD 81.06(5)(b)1.b.b. Maximum treatment frequency is once per week to any one site if there is a positive response to the first injection at that site. If subsequent injections at that site demonstrate diminishing control of symptoms or fail to facilitate objective functional gains, then trigger point injections shall be redirected to other areas or discontinued. No more than 3 injections to different sites per patient visit may be given. DWD 81.06(5)(b)2.2. All of the following guidelines apply to sacroiliac joint injections: DWD 81.06(5)(b)2.b.b. Maximum treatment frequency may permit repeat injection 2 weeks after the previous injection if there is a positive response to the first injection. Only 2 injections per patient visit. DWD 81.06(5)(b)3.3. All of the following guidelines apply to facet joint or nerve injections: DWD 81.06(5)(b)3.b.b. Maximum treatment frequency is once every 2 weeks to any one site if there is a positive response to the first injection. If subsequent injections demonstrate diminishing control of symptoms or fail to facilitate objective functional gains, then injections shall be discontinued. Only 3 injections to different sites per patient visit. DWD 81.06(5)(b)4.b.b. Maximum treatment frequency may permit repeat injection 2 weeks after the previous injection if there is a positive response to the first injection. Only 3 injections to different sites per patient visit. DWD 81.06(5)(b)4.c.c. Maximum treatment is 2 injections to any one site. Maximum treatment is 2 injections to any one site. DWD 81.06(5)(b)5.b.b. Maximum treatment frequency is once every 2 weeks if there is a positive response to the first injection. If subsequent injections demonstrate diminishing control of symptoms or fail to facilitate objective functional gains, then injections should be discontinued. Only one injection per patient visit. DWD 81.06(5)(c)(c) For purposes of this paragraph, “lytic or sclerosing injections” include radio frequency denervation of the facet joints. These injections may only be given in conjunction with active treatment modalities directed to the same anatomical site. All of the following guidelines apply to lytic or sclerosing injections: DWD 81.06(5)(c)2.2. Maximum treatment frequency may repeat 4 times per year or once every 3 months for any site.
/code/admin_code/dwd/080_081/81
true
administrativecode
/code/admin_code/dwd/080_081/81/06/3/f/2/a
Department of Workforce Development (DWD)
Chs. DWD 80-81; Worker’s Compensation
administrativecode/DWD 81.06(3)(f)2.a.
administrativecode/DWD 81.06(3)(f)2.a.
section
true
